Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1707515 | 0.87 | CASP1 (0.88) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL1707604 | 0.87 | CASP1 (1.00) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL11334327 | 0.84 | CASP1 (0.83) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL27570534 | 0.84 | CASP1 (0.65) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL10454786 | 0.84 | CASP1 (0.83) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL7174047 | 0.82 | CASP1 (0.62) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL671139 | 0.82 | CASP1 (0.62) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL27574589 | 0.80 | CASP1 (0.59) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL1707608 | 0.79 | CASP1 (0.58) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 | |
| SCHEMBL11306480 | 0.78 | CASP1 (0.56) | CASP1CYP1A2TSHRSMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0044424-B1 | FIRE-PROOF POLYAMIDE MOULDING AND SUCH-LIKE MOULDED ARTICLES | BAYER AG (DE) | 1984-04-25 | — | — | EP | claimed |
| EP-0044419-B1 | FIRE-PROOF POLYAMIDE MOULDINGS | BAYER AG (DE) | 1984-04-04 | — | — | EP | claimed |
| US-4208320-A | Flame retardant resin composition comprising reaction product of polyguanamine compound and cyanuric or isocyanuric acid compound | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-06-17 | — | — | US | claimed |
| EP-4685185-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, LAMINATE, AND CURABLE COMPOUND | DIC Corporation (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4685172-A1 | CURABLE COMPOUND, CURABLE RESIN COMPOSITION, CURED ARTICLE AND LAMINATE | DIC Corporation (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4685171-A1 | CURABLE COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC Corporation (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2025-12-23 | — | — | US | disclosed |
| EP-4663646-A1 | PHOSPHORUS COMPOUND, METHOD FOR SYNTHESIZING SAME, AND USE THEREFOR | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-12-17 | — | — | EP | disclosed |
| EP-4663669-A1 | FLAME RETARDANT AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-12468104-B2 | Optical cable | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250320180-A1 | HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT | DIC CORPORATION (JP) | 2025-10-16 | — | — | US | disclosed |
| US-4433085-A | Triazolidine-3,5-dione/formaldehyde/amine condensates and compositions thereof | BAYER AKTIENGESELLSCHAFT (DE) | 1984-02-21 | — | — | US | disclosed |
| EP-0044423-B1 | TRIAZOLIDINE-3,5-DIONE SALTS AND THEIR USE IN THE MODIFICATION OR FIRE-RESISTANT FINISHING OF POLYMERS | BAYER AG (DE) | 1983-09-28 | — | — | EP | disclosed |
| US-4396736-A | TRIAZOLIDINE-3,5-DIONES OR DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-08-02 | — | — | US | disclosed |
| EP-0044424-A1 | Fire-proof polyamide moulding and such-like moulded articles | BAYER AG (DE) | 1982-01-27 | — | — | EP | disclosed |
| EP-0044419-A1 | Fire-proof polyamide mouldings | BAYER AG (DE) | 1982-01-27 | — | — | EP | disclosed |
| EP-0044417-A2 | Triazolidine-3,5-dione condensed with amine-formaldehyde, and its preparation | BAYER AG (DE) | 1982-01-27 | — | — | EP | disclosed |
| EP-0044423-A1 | Triazolidine-3,5-dione salts and their use in the modification or fire-resistant finishing of polymers | BAYER AG (DE) | 1982-01-27 | — | — | EP | disclosed |
| US-4249004-A | FIREPROOFING FOR POLYMERS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1981-02-03 | — | — | US | disclosed |
| US-4208320-A | Flame retardant resin composition comprising reaction product of polyguanamine compound and cyanuric or isocyanuric acid compound | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320180-A1 | HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT | RAD51, SEM1, GFER | CASP1 453/4885CYP1A2 865/4885TSHR 4063/4885 |
| US-12503480-B2 | Cyclic phosphazene compound having oxaphosphorin ring-containing structure | PFAS, PHOSPHO1, PAF1 | CASP1 1133/4885CYP1A2 3817/4885TSHR 3387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.